Related references
Note: Only part of the references are listed.Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients
Alessandra Romano et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Construction of nanoparticleS based on amphiphilic copolymers of poly(gamma-glutamic acid co-L-lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine as a potential drug delivery carrier
Xiaoguang Liu et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2014)
Ultrabright and Multicolorful Fluorescence of Amphiphilic Polyethyleneimine Polymer Dots for Efficiently Combined Imaging and Therapy
Yun Sun et al.
SCIENTIFIC REPORTS (2013)
Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles
Qing Xu et al.
BIOMATERIALS (2012)
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer
Benjamin Besse et al.
LUNG CANCER (2012)
Theranostic Nanoshells: From Probe Design to Imaging and Treatment of Cancer
Rizia Bardhan et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Nanomaterials: Applications in Cancer Imaging and Therapy
Jose A. Barreto et al.
ADVANCED MATERIALS (2011)
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles
Hai Wang et al.
BIOMATERIALS (2011)
Lipoic Acid Modified Low Molecular Weight Polyethylenimine Mediates Nontoxic and Highly Potent in Vitro Gene Transfection
Meng Zheng et al.
MOLECULAR PHARMACEUTICS (2011)
Nanostructured polymer assemblies formed at interfaces: applications from immobilization and encapsulation to stimuli-responsive release
Yajun Wang et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2011)
Encapsulation of Water-Insoluble Drugs in Polymer Capsules Prepared Using Mesoporous Silica Templates for Intracellular Drug Delivery
Yajun Wang et al.
ADVANCED MATERIALS (2010)
A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors
Bhuvaneswari Ramaswamy et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer
Bin Wang et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
Giorgio V. Scagliotti et al.
LUNG CANCER (2010)
Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation
Wei Wei et al.
NANOMEDICINE (2010)
Stability of unused reconstituted bortezomib in original manufacturer vials
Joshua P Vanderloo et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2010)
Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines
Francesca Greco et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells
Cecilia Ceresa et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Yogeshkumar Malam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours
S. Cresta et al.
EUROPEAN JOURNAL OF CANCER (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines
Jens Wagenblast et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Polymeric micellar pH-sensitive drug delivery system for doxorubicin
M Hruby et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel
SS Feng et al.
CURRENT MEDICINAL CHEMISTRY (2004)
The Bcl-2 family: roles in cell survival and oncogenesis
S Cory et al.
ONCOGENE (2003)
Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib
JC Cusack
CANCER TREATMENT REVIEWS (2003)
Share Paper
